71 related articles for article (PubMed ID: 12830143)
1. The problem of plain vanilla peptides.
Davis MM
Nat Immunol; 2003 Jul; 4(7):649-50. PubMed ID: 12830143
[No Abstract] [Full Text] [Related]
2. A structural basis for immunodominant human T cell receptor recognition.
Stewart-Jones GB; McMichael AJ; Bell JI; Stuart DI; Jones EY
Nat Immunol; 2003 Jul; 4(7):657-63. PubMed ID: 12796775
[TBL] [Abstract][Full Text] [Related]
3. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 1996. 384: 134-141.
Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
J Immunol; 2010 Dec; 185(11):6394-401. PubMed ID: 21084668
[No Abstract] [Full Text] [Related]
4. Immunodominant-peptide recognition: beta testing TCRalphabeta.
Wang JH; Mallis RJ; Reinherz EL
Immunity; 2008 Feb; 28(2):139-41. PubMed ID: 18275824
[TBL] [Abstract][Full Text] [Related]
5. Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2.
Gagnon SJ; Turner RV; Shiue MG; Damirjian M; Biddison WE
Mol Immunol; 2006 Feb; 43(4):346-56. PubMed ID: 16310048
[TBL] [Abstract][Full Text] [Related]
6. T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding.
Cole DK; Dunn SM; Sami M; Boulter JM; Jakobsen BK; Sewell AK
Mol Immunol; 2008 May; 45(9):2700-9. PubMed ID: 18243322
[TBL] [Abstract][Full Text] [Related]
7. Assembly and crystallization of the complex between the human T cell coreceptor CD8alpha homodimer and HLA-A2.
Gao GF; Gerth UC; Wyer JR; Willcox BE; O'Callaghan CA; Zhang Z; Jones EY; Bell JI; Jakobsen BK
Protein Sci; 1998 May; 7(5):1245-9. PubMed ID: 9605330
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics study of a complex between the human histocompatibility antigen HLA-A2 and the IMP58-66 nonapeptide from influenza virus matrix protein.
Rognan D; Zimmermann N; Jung G; Folkers G
Eur J Biochem; 1992 Aug; 208(1):101-13. PubMed ID: 1511679
[TBL] [Abstract][Full Text] [Related]
9. Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients.
Wieckowski S; Baumgaertner P; Corthesy P; Voelter V; Romero P; Speiser DE; Rufer N
J Immunol; 2009 Oct; 183(8):5397-406. PubMed ID: 19786555
[TBL] [Abstract][Full Text] [Related]
10. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
[TBL] [Abstract][Full Text] [Related]
11. Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer.
Elkord E; Williams PE; Kynaston H; Rowbottom AW
Int Immunol; 2005 Oct; 17(10):1315-25. PubMed ID: 16141246
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional characterization of peptide-beta2m fused HLA-A2/MART1(27-35) complexes.
Shen C; Chang CC; Zhang J; Guo W; Xia L; Meng F; Xie W
Biochem Biophys Res Commun; 2006 Mar; 342(1):57-65. PubMed ID: 16472765
[TBL] [Abstract][Full Text] [Related]
13. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.
Iancu EM; Corthesy P; Baumgaertner P; Devevre E; Voelter V; Romero P; Speiser DE; Rufer N
J Immunol; 2009 Jul; 183(1):319-31. PubMed ID: 19542443
[TBL] [Abstract][Full Text] [Related]
14. A tale of two T cells.
Janeway CA
Immunity; 1998 Apr; 8(4):391-4. PubMed ID: 9586629
[No Abstract] [Full Text] [Related]
15. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
Shang XY; Chen HS; Zhang HG; Pang XW; Qiao H; Peng JR; Qin LL; Fei R; Mei MH; Leng XS; Gnjatic S; Ritter G; Simpson AJ; Old LJ; Chen WF
Clin Cancer Res; 2004 Oct; 10(20):6946-55. PubMed ID: 15501973
[TBL] [Abstract][Full Text] [Related]
16. Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.
Suneetha PV; Schlaphoff V; Wang C; Stegmann KA; Fytili P; Sarin SK; Manns MP; Cornberg M; Wedemeyer H
J Immunol Methods; 2009 Mar; 342(1-2):33-48. PubMed ID: 19135447
[TBL] [Abstract][Full Text] [Related]
17. The nitty-gritty of protein interactions.
Schreiber G
Structure; 2005 Dec; 13(12):1737-8. PubMed ID: 16338399
[No Abstract] [Full Text] [Related]
18. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
[TBL] [Abstract][Full Text] [Related]
19. Identification of T cell epitopes by the use of rapidly generated mRNA fragments.
Britten CM; Meyer RG; Graf C; Huber C; Wölfel T
J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199
[TBL] [Abstract][Full Text] [Related]
20. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
Jansen CA; Kostense S; Vandenberghe K; Nanlohy NM; De Cuyper IM; Piriou E; Manting EH; Miedema F; van Baarle D
Eur J Immunol; 2005 Jan; 35(1):150-8. PubMed ID: 15593302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
